Ensifentrine: "Significant and clinically meaningful improvements in lung function at Week 12"; Chronic obstructive pulmonary disease (Verona Pharma) - Aug 18, 2022 - ENHANCE-2 Phase 3 Top-Line Data and Q2 Results Conference Call
P3 data: top line • Chronic Obstructive Pulmonary Disease • Immunology
|